Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder

NCT05254405 is registered in ClinicalTrials.gov with Donald Jeffrey Newport as lead sponsor.

NCT NCT05254405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05254405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
Lead sponsor
Donald Jeffrey Newport
Phase
Phase 4
Overall status
Terminated
Start date
June 1, 2023
Completion date
December 30, 2025
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder